
![]() |
|
Murali Chakinala, M.D. Assistant Professor of Medicine
CONTACT INFORMATION
Washington University School of Medicine EDUCATION/TRAINING
Undergraduate education: Duke University (1986 90) B.A. POSITIONS Assistant Professor, Division of General Internal Medicine: University of Texas Southwestern (1998 99) Assistant Professor, Division of Pulmonary & Critical Care Medicine: Washington University (2002 present) OTHER EXPERIENCE AND PROFESSIONAL MEMBERSHIPS
American College of Physicians ACADEMIC HONORS
Alpha Omega Alpha (AOA), Vanderbilt Medical School; 9/93 PUBLICATIONS Chakinala MM and Trulock EP. Acute Rejection: Diagnosis and Management. Chest Surgery Clinics of North America. 2003; 13:525-542. Chakinala MM, Ritter J, Gage BF, Aloush AA, Trulock EP. Inter-reader and Intra-reader Agreement for Grading Acute Rejection and Airway Inflammation after Lung Transplantation, Based on the Lung Rejection Study Group Revised Working Formulation. (Abs.) J Heart Lung Transplant (accepted 11/02). Chakinala MM and Schuller DS. Evaluation and Management of Pulmonary Hypertension. Washington University House-officers Sub-specialty Manual. (in press). Chakinala MM, Ritter J, Gage BF, Aloush AA, Trulock EP. Yield of Surveillance Bronchoscopy after Lung Transplantation. Journal of Heart Lung Transplant (in press). Chakinala MM, Kollef M, Trulock EP. Critical Care aspects of Lung Transplant Patients. Journal of Intensive Care Medicine 2002; 17 (1). Chakinala MM and Schuster DP. Pulmonary Edema in: Fishman AP, ed. Fishmans Manual of Pulmonary Diseases and Disorders, 3rd ed.; New York: McGraw-Hill. RESEARCH SUPPORT
PI for "A multicentre, randomized, doubl-blind, parallel group, placebo-controlled study to investigate the long-term effects of salmeterol/fluticasone propionate on the survival of subjects with COPD." (Glaxo - SCO30003)
PI for "Multicenter, randomised, placebo-controlled trial to assess the safety and efficacy of a subject optimsed dose of sildenafil, when used in combination with intravenous prostacyclin in the treatment of pulmonary arterial hypertension." (Pfizer)
Division of Pulmonary and Critical Care Medicine
|